Emerging immunotherapies for glioblastoma

Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research

Adjuvant dendritic cell vaccination induces tumor-specific immune responses in the majority of stage III melanoma patients

Oncolytic virotherapy for urological cancers

In Hyperthermia Increased ERK and WNT Signaling Suppress Colorectal Cancer Cell Growth

Genetic Modification of Oncolytic Newcastle Disease Virus for Cancer Therapy

Dendritic cell-based cancer immunotherapy for colorectal cancer

Newcastle disease virus chimeras expressing the Hemagglutinin- Neuraminidase protein of mesogenic strain exhibits an enhanced anti-hepatoma efficacy

Cancer Vaccines in Ovarian Cancer: How Can We Improve?

Extended Tumor Control after Dendritic Cell Vaccination with Low-Dose Cyclophosphamide as Adjuvant Treatment in Patients with Malignant Pleural Mesothelioma